geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Vascularity change and tumor response to neoadjuvant chemotherapy for advanced breast cancer


, : Vascularity change and tumor response to neoadjuvant chemotherapy for advanced breast cancer. Ultrasound in Medicine & Biology 34(6): 857-866

For advanced breast cancer with severe local disease (ABC) (stage HUM, neoadjuvant chemotherapy improves local control and surgical outcome. However, about similar to 20 to 30% of advanced cancers show either no or poor response to chemotherapy. To prevent unnecessary treatment, a capability of predicting clinical response to neoadjuvant chemotherapy of ABC is highly desirable. Vascularity index (VI) of breast cancers was derived from the quantification results in 30 ABC patients by using power Doppler sonography. Power Doppler sonography evaluation was performed every one to two weeks during chemotherapy. The overall response rate for 30 advanced patients tested was 70%, when 50% or more reduction in tumor size was the objective clinical response. Chemotherapy response was unrelated to the original tumor size (p = 0.563) or chemotherapy agents used (p = 0.657). The median VI for all 30 patients was 4.99%. The response rates for hypervascular tumors vs. hypovascular tumors, based on initial median value, were 86.7% and 53.3%, respectively (p = 0.109). The average VIs in responders and nonresponders were 7.67 +/- 4.77% and 4.01 +/- 3.82% (p = 0.052). There was a tendency for responders who have a relatively high initial vascularity. The VI change in responder group shows a pattern of initial increasing in vascularity followed by decreasing in vascularity. All patients (17/17) with a VI increment of > 5% during chemotherapy had good chemotherapy response, whereas in patients with a VI increment of < 5%, the response rate was 30.8% (4/13) (p < 0.001). For patients with a peak VI of > 10% during chemotherapy, the response rate was 94.1% (16/17). However, in patients with a peak VI of < 10%, the response rate was 38.5% (5/13) (p = 0.001). This prediction was made mostly within one month (25.47 +/- 12.96 d for VI increments > 5% and 25.44 +/- 12.41 d for VI increased to > 10%). In the meantime, the differences in size reduction shown in B-mode sonography were insignificant between responders and nonresponders (patient group with VI increment > 5%,p = 0.308; patient group with peak VI > 10%,p = 0.396). In conclusion, we propose that VI as determined by using power Doppler sonography is a good and inexpensive clinical tool for monitoring vascularity changes during neoadjuvant chemotherapy in ABC patients. Two parameters-VI increment > 5% and peak VI > 10%-are potential early predictors for good responses to neoadjuvant chemotherapy within one month in patients with ABC. (E-mail: kingjen@ha.mc.ntu.edu.tw) (c) 2008 Published by Elsevier Inc. on behalf of the World Federation for Ultrasound in Medicine & Biology.

US$19.90

PMID: 18374468

DOI: 10.1016/j.ultrasmedbio.2007.11.011


Other references

Lossos, I.S.; Okon, E.; Bogomolski-Yahalom, V.; Ron, N.; Polliack, A., 1997: Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): Report of a patient with isolated renotesticular involvement after cure of non-Hodgkin's lymphoma. Sinus histiocytosis with massive lymphadenopathy (SHML) - Rosai-Dorfman disease - is a rare but well-defined benign histiocytic proliferative disorder. We report an unusual patient. cured of non-Hodgkin's lymphoma, who presented 12 years late...

Mackinnon, S., 1997: Donor leukocyte infusions. Donor leukocyte therapy has resulted in a remission rate in excess of 70% in patients with relapse of chronic myeloid leukaemia (CML) following allogeneic bone marrow transplantation (BMT). Induction of remission with donor leukocyte infusions has...

Sidner, R.; Davis, R., 1988: Records of nectar-feeding bats in Arizona. Southwestern Naturalist, 334: 493-495

Lerman, J.; Jöhr, M., 2009: Inhalational anesthesia vs total intravenous anesthesia (TIVA) for pediatric anesthesia. Paediatric Anaesthesia 19(5): 521-534

Ahui, B.J-M.; Horo, K.; Bakayoko, A.S.; Kouassi, A.B.; Anon, J.C.; Brou-Gode, V.C.; Koffi, M.O.; Itchy, M.V.; N'Gom, A.S.; N'Goran, N.B.; Aka-Danguy, E., 2014: Evaluation of multidrug-resistant tuberculosis treatment in Ivory Coast from 2008 to 2010. This is a retrospective study conducted from January 2008 to December 2010 on sectional descriptive analysis of records of patients treated for MDR-TB and whose follow-up was in the thoracic department of Centre Hospitalier Universitaire (CHU) of...

Chen, W.; Jin, W.; Wahl, S.M., 1998: Engagement of cytotoxic T lymphocyte-associated antigen 4 induces transforming growth factor beta production by murine CD4+ T cells. Evidence indicates that cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) may negatively regulate T cell activation, but the basis for the inhibitory effect remains unknown. We report here that cross-linking of CTLA-4 induces transforming growt...

Giessen-Jung, C.; Nagel, D.; Glas, M.; Spelsberg, F.; Lau-Werner, U.; Modest, D.Paul.; Schulz, C.; Heinemann, V.; D.G.oia, D.; Stieber, P., 2016: Preoperative serum markers for individual patient prognosis in stage I-III colon cancer. Carcinoembryonic antigen (CEA) remains the only recommended biomarker for follow-up care of colorectal cancer (CRC), but besides CEA, several other serological parameters have been proposed as prognostic markers for CRC. The present retrospective...

Anonymous, 2013: Síndrome metabolico y actividad física en inmigrantes chilenos residentes en río gallegos, santa cruz, argentina. Estudiar la frecuencia de s ndrome metab lico, sus componentes y su relaci n con la actividad f sica, en inmigrantes chilenos residentes en R o Gallegos, Santa Cruz, Argentina. Se entrevistaron a 314 (165 mujeres y 149 hombres) inmigrantes residen...

Rudler, J.C.; Angles, C.; Megevand, R., 1963: Postoperative Mortality After Resection In Cancer Of The Middle Segment Of The Thoracic Esophagus. Improvement Of Results By Use Of The Engstroem Respirator During Anesthesia. Thoraxchirurgie und Vaskulare Chirurgie 11: 95-99

Grujicic, G., 1971: Stem nematode (Ditylenchus dipsaci Kuhn) with reference to host plants in Serbia. Zastita Bilja(114): 159-171